Confirms coverage and documents screening versus diagnostic intent before the colonoscopy or EGD is scheduled, since that decision determines which modifier the claim needs later.
Gastroenterology Medical Billing Services for Colonoscopy, EGD & ERCP Claims
From screening and diagnostic colonoscopies to EGD, ERCP, capsule endoscopy, and biologic infusions for IBD, we bill every corner of a GI practice.
🔒 100% confidential. We never sell your data. Privacy Policy
Thrive manages the billing side of your gastroenterology practice so your physicians can stay focused on patients instead of chasing payers. That means coding every colonoscopy and EGD by the polypectomy or biopsy technique actually used, applying modifier PT or 33 correctly the moment a screening procedure turns diagnostic, and following up on every claim until it is paid or resolved.
Practices that choose Thrive as their gastroenterology medical billing company get a team that already knows screening conversion rules, NCCI bundling edits, and biologic infusion documentation, instead of a generalist biller treating every endoscopy the same way. Whether your practice is general GI, an advanced endoscopy program, or a hepatology practice, the coding rules overlap enough to share one trained team and diverge enough that generalist billers consistently get them wrong.
Gastroenterology billing services carry a wide procedure mix in a single visit, screening and diagnostic endoscopy, biopsy, polypectomy, and increasingly biologic infusion for IBD. Here is what we handle from the first eligibility check to the final payment.
Confirms coverage and documents screening versus diagnostic intent before the colonoscopy or EGD is scheduled, since that decision determines which modifier the claim needs later.
Secures and tracks authorization for capsule endoscopy, ERCP, manometry, and biologic infusions across commercial and Medicare Advantage plans.
Checks every colonoscopy and EGD code against polypectomy technique, biopsy site, and modifier requirements before a claim leaves the building.
Traces denials to their actual cause, whether a PT or 33 mismatch or a bundling edit, and appeals with the operative documentation each payer requires.
Works open claims on a set schedule so endoscopy and infusion balances do not sit past 30 days unattended.
Bills patients clearly when a screening procedure converts to diagnostic, since that shift can change what the patient owes under their plan.
Reconciles biologic infusion reimbursement against the actual dose administered, so drug cost overruns get caught early.
Keeps gastroenterologists credentialed and enrolled with the payers your patients actually carry.
Regular reporting on claim status, denial trends, and AR aging broken out by endoscopy, infusion, and diagnostic test categories.
A quick reference to how gastroenterology billing codes are organized, not a substitute for chart documentation. Useful for seeing where a specific claim fits before it is coded.
These are not generic billing problems. Each one is specific to how payers adjudicate colonoscopy, endoscopy, and infusion claims.
The wrong modifier, or no modifier at all, when a screening colonoscopy converts to therapeutic after a polyp is found and removed causes an automatic denial and can leave the patient billed incorrectly for a preventive service.
Billing a biopsy and a polypectomy performed at different sites in the same colonoscopy without modifier 59 or XS support gets denied as an unbundled service under NCCI edits.
A colonoscopy stopped before reaching the cecum due to poor bowel prep or patient intolerance billed without modifier 52 gets processed as a completed procedure, creating both a denial risk and an overpayment exposure.
Capsule endoscopy, esophageal manometry, and ERCP billed without payer pre-approval get denied outright, regardless of how clearly medically necessary the test was.
Coding a polyp removal as snare when the operative note documents hot forceps, or the reverse, does not match the code billed to the technique performed and triggers a downcode or denial on review.
Infliximab and other biologic infusions for Crohn’s disease or ulcerative colitis are denied without documented step therapy failure and current weight-based dosing on file before the infusion.
Billing sedation separately when it is bundled into the base endoscopic procedure, or missing documentation supporting medically necessary monitored anesthesia care, causes denial or recoupment.
Repeat stool-based screening tests or surveillance colonoscopies billed before the payer’s allowed interval has elapsed are denied regardless of the clinical reason for repeating them.
Every step below exists because of a specific denial pattern above. Nothing here is generic.
Practices that switch to Thrive get a gastroenterology medical billing company built around endoscopy coding and screening conversion rules specifically, not generic revenue cycle coverage stretched across every specialty.
We will look at your current claim volume, denial patterns, and procedure mix, endoscopy heavy, infusion heavy, or general, and put together a custom fee schedule and a revenue recovery estimate. No obligation.
🔒 100% confidential. We never sell your data. Privacy Policy
When colonoscopy claims, procedure denials, authorization gaps, patient balance questions, or old AR keep resurfacing, the problem is usually bigger than one unpaid claim. Thrive can review the workflow and show where your GI billing process needs tighter follow-up.
At Thrive Medical Billing, we specialize in providing precise, efficient, and personalized medical billing services. As a trusted medical billing company, we are committed to helping your practice succeed by handling all your billing needs, allowing you to focus on what matters most—providing exceptional care to your patients. Partner with us to elevate your practice and experience growth—because when your practice thrives, so do we.
Maximize Your Revenue with Expert Medical Billing & Coding Services
Fill out the form below, and let’s create a customized solution for your practice.